Castle Biosciences, Inc.
CSTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $120 | $99 | $123 | $330 |
| Short-Term Investments | $173 | $144 | $136 | $0 |
| Receivables | $51 | $38 | $23 | $17 |
| Inventory | $8 | $8 | $4 | $2 |
| Other Curr. Assets | $8 | $6 | $6 | $5 |
| Total Curr. Assets | $360 | $296 | $292 | $354 |
| Property Plant & Equip (Net) | $63 | $38 | $26 | $17 |
| Goodwill | $11 | $11 | $11 | $0 |
| Intangibles | $96 | $107 | $116 | $89 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $2 | $3 |
| Total NC Assets | $171 | $158 | $155 | $109 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $531 | $453 | $447 | $463 |
| Liabilities | – | – | – | – |
| Payables | $7 | $10 | $5 | $3 |
| Short-Term Debt | $2 | $1 | $2 | $1 |
| Tax Payable | $1 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $39 | $36 | $30 | $20 |
| Total Curr. Liab. | $49 | $48 | $36 | $25 |
| LT Debt | $24 | $14 | $12 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $0 | $0 | $1 |
| Other NC Liab. | $0 | $0 | $0 | $18 |
| Total NC Liab. | $26 | $14 | $12 | $26 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $16 | $15 | $13 | $8 |
| Total Liabilities | $75 | $62 | $48 | $51 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$200 | -$218 | -$161 | -$94 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $656 | $609 | $560 | $505 |
| Total Equity | $456 | $391 | $399 | $412 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $531 | $453 | $447 | $463 |
| Net Debt | -$93 | -$84 | -$110 | -$321 |